These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4261258)

  • 1. Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer.
    Smith GF; Bang NU
    Biochemistry; 1972 Aug; 11(16):2958-66. PubMed ID: 4261258
    [No Abstract]   [Full Text] [Related]  

  • 2. Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.
    Mosesson MW; Finlayson JS; Umfleet RA; Galanakis D
    J Biol Chem; 1972 Aug; 247(16):5210-9. PubMed ID: 4262568
    [No Abstract]   [Full Text] [Related]  

  • 3. Precipitation of 125 I-labeled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide compositions in human high density lipoproteins.
    Albers JJ; Aladjem F
    Biochemistry; 1971 Aug; 10(18):3436-42. PubMed ID: 5000816
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4.
    Sherman LA; Mosesson MW; Sherry S
    Biochemistry; 1969 Apr; 8(4):1515-23. PubMed ID: 4241001
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of soluble fibrin complexes by agarose gel chromatography and protamine sulfate gelation.
    Latallo ZS; Mattler LE; Bang NU; Hansen MS; Chang ML
    Biochim Biophys Acta; 1976 Jan; 420(1):69-80. PubMed ID: 1247582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen-fibrin conversion. The mechanism of fibrin-polymer formation in solution.
    Smith GF
    Biochem J; 1980 Jan; 185(1):1-11. PubMed ID: 7378042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of blood coagulation by soluble fibrin complexes.
    Hansen MS; Bang NU; Barton RD; Mattler LE
    J Exp Med; 1975 May; 141(5):944-61. PubMed ID: 805207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
    Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1973; 56():91-112. PubMed ID: 4281941
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular structure of fibrinogen.
    Blombäck B; Blombäck M
    Ann N Y Acad Sci; 1972 Dec; 202():77-97. PubMed ID: 4118185
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen.
    Marder VJ
    Scand J Haematol Suppl; 1971; 13():21-36. PubMed ID: 4258202
    [No Abstract]   [Full Text] [Related]  

  • 12. Properties of thrombin and fibrinolysin lysed fibrin.
    Triantaphyllopoulos DC; Muirhead CR; Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1969; 36():269-76. PubMed ID: 5375545
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmic degradation of human fibrinogen. I. Structural characterization of degradation products.
    Furlan M; Beck EA
    Biochim Biophys Acta; 1972 May; 263(3):631-44. PubMed ID: 4260762
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterisation and comparison of macromolecular end products of fibrinogen and fibrin proteolysis by plasmin.
    Dudek GA; Kloczewiak M; Budzyński AZ; Latallo ZS; Kopeć M
    Biochim Biophys Acta; 1970 Jul; 214(1):44-51. PubMed ID: 4249862
    [No Abstract]   [Full Text] [Related]  

  • 15. The interaction of light chain fragments with heavy chain from immunoglobulin G.
    Smith BR; Dorrington KJ
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1061-5. PubMed ID: 5012159
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Mosesson MW
    Thromb Diath Haemorrh Suppl; 1973; 56():75-90. PubMed ID: 4218377
    [No Abstract]   [Full Text] [Related]  

  • 17. Nature of the high molecular weight fraction of fibrinolytic digests of human fibrinogen.
    Jamieson GA; Gaffney PJ
    Biochim Biophys Acta; 1968 Jan; 154(1):96-109. PubMed ID: 4230213
    [No Abstract]   [Full Text] [Related]  

  • 18. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
    Shinada S
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
    [No Abstract]   [Full Text] [Related]  

  • 19. Subunit structure of the plasmin-induced degradation products of crosslinked fibrin.
    Gaffney PJ; Brasher M
    Biochim Biophys Acta; 1973 Jan; 295(1):308-13. PubMed ID: 4265363
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen break-down products and clotting parameters.
    Gormsen J; Laursen B
    Thromb Diath Haemorrh; 1967 May; 17(3-4):467-81. PubMed ID: 4231951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.